Latest Blogs

Sep 16, 2021
Dr. Atlal Abusanad discusses how biases in valuing capability and potential in female oncologists has led to their underrepresentation in prominent roles. 
Sep 14, 2021
My colleague and friend Christine McGinn discusses the experience of caregiving for her brother, and the lessons she now brings to her own practice.
Sep 09, 2021
"I think of my fellowship studies as a series of layers—every time I do well at one layer, I am ready to move to the next one," said Dr. Tarek Haykal.
Sep 01, 2021
There has never been a more exciting time to be involved in cancer research, with so much knowledge to support our explorations and so many pressing questions still to answer.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).

Disclosure.

Jun 30, 2021
ASCO’s delegation to the American Medical Association (AMA) recently met virtually with the AMA’s House of Delegates (HOD), with a focus on payment reform models. 
Dec 02, 2020
Despite the virtual nature of the AMA House of Delegates meeting, the decisions made there have a very real impact on our profession and the patients we serve.
Jun 10, 2020
Although our societal meetings, including the AMA House of Delegates meeting, are shortened, they have never been more important than they are at this moment.
Dec 03, 2019
ASCO's delegation to the AMA HOD invites all ASCO members to share their thoughts and concerns concerning issues affecting the practice of oncology, as your input directly impacts the delegation's work.
Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Nov 19, 2018
At a recent meeting, the ASCO delegation to the AMA House of Delegates presented concerns focused on the Competitive Acquisition Program (CAP), among a variety of other issues.

Pages